Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Daily News

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

Caitlin E. Cox

February 02, 2026

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News AHA 2024

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Michael O'Riordan

November 16, 2024

News Features

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

Todd Neale

November 13, 2024

News Daily News

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

L.A. McKeown

October 01, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Conference News ESC Heart Failure 2024

Remote Monitoring in Real-world HF Cuts All-Cause Mortality: TELESAT-HF

Michael O'Riordan

May 12, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Daily News

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Todd Neale

September 13, 2023

News Conference News ACC 2023

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

L.A. McKeown

March 14, 2023

News Daily News

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

L.A. McKeown

January 13, 2023

News Conference News HFSA 2022

New Dapagliflozin Insights: Early Benefits and Types of Deaths Prevented

Todd Neale

October 07, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Daily News

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

L.A. McKeown

June 21, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Conference News HFSA 2021

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Michael O'Riordan

September 14, 2021

Advertisement

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

April 2025 Dispatch for the CV Team

December 2024 Dispatch for the CV Team

November 2024 Dispatch for the CV Team

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

Remote Monitoring in Real-world HF Cuts All-Cause Mortality: TELESAT-HF

May 2024 Dispatch for the CV Team

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

New Dapagliflozin Insights: Early Benefits and Types of Deaths Prevented

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content